Prostate cancer treated with androgen deprivation therapy has consequences for bone.

about

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

Item

http://www.wikidata.org/entity/Q48381608

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年学术文章

@wuu

2013年学术文章

@zh

2013年学术文章

@zh-cn

2013年学术文章

@zh-hans

2013年学术文章

@zh-my

2013年学术文章

@zh-sg

2013年學術文章

@yue

2013年學術文章

@zh-hant

name

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@en

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@nl

type

Item

label

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@en

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@nl

prefLabel

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@en

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@nl

P1476

Prostate cancer treated with androgen deprivation therapy has consequences for bone.

@en

P2093

Robert A Adler

http://www.w3.org/2001/XMLSchema#string

P2860

Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancer

Bicalutamide monotherapy preserves bone mineral density, muscle strength and has significant health-related quality of life benefits for osteoporotic men with prostate cancer.

Denosumab in men receiving androgen-deprivation therapy for prostate cancer

Obesity and sex steroids during gonadotropin-releasing hormone agonist treatment for prostate cancer.

Prevalence of osteopenia and osteoporosis by central and peripheral bone mineral density in men with prostate cancer during androgen-deprivation therapy.

Management of osteoporosis in men on androgen deprivation therapy.

Glucocorticoid-induced osteoporosis in men.

Prevalence of osteoporosis in prostate cancer survivors: a meta-analysis.

Changes in bone mineral density in men starting androgen deprivation therapy and the protective role of vitamin D.

Treatment thresholds for osteoporosis in men on androgen deprivation therapy: T-score versus FRAX.

P2888

s12020-013-0113-x

P304

339-340

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

editorial

P356

10.1007/S12020-013-0113-X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-12-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24366636

http://www.w3.org/2001/XMLSchema#string